For antimicrobial testing, Haemophilus Test Agar Culture Media sits at the point where organism growth becomes a quantitative or categorical measurement. The discussion below connects its documented role with preparation variables, controls, interpretation, and the limits of inference. Catalogue 10080 is discussed as a laboratory measurement component; implementation should follow the laboratory SOP and validated reference method.
Analytical scope and method role
Haemophilus Test Agar is a medium specifically formulated for the susceptibility testing of Haemophilus influenzae as standardized by the Clinical and Laboratory Standards Institute (CLSI).
Method principle
Beef extract and acid hydrolysate of casein supply amino acids and other nitrogenous substances, minerals, vitamins, carbon and other nutrients to support the growth of microorganisms. Starch acts as a protective colloid against toxic substances that may be present in the medium. Beside hydrolysis of starch during autoclaving provides a small amount of glucose which is a source of energy. Yeast extract supplies amino acids and vitamins of group B. Agar is the solidifying agent. Nicotinamide Adenine Dinucleotide (NAD) and haematin are further growth supplements for Haemophilus influenzae which is a fastidious microorganism and requires complex media for growth.
Formula and functional interpretation
(g/l)Beef Extract 2.0Acid Hydrolysate of Casein17.5Starch 1.5Yeast Extract 5.0Agar15.0NAD 0.015Haematin 0.015Final pH 7.4 ± 0.2
Review the nutritive, selective, differential, buffering, reducing, and indicator components against the expected target and background flora. Preparation errors can change recovery, inhibition, colour development, or endpoint visibility even when incubation is correct.
Preparation and execution: controlled method points
Procedure: 1.Prepare a standardized suspension of the test organism using either the direct colony suspension or growth method. 2.Dip a sterile cotton swab into the adjusted suspension. 3.Inoculate the surface of the plate by streaking the swab over the entire agar surface. 4.Apply the antimicrobial discs onto the surface of the inoculated agar plate. 5.Incubate at 35 ± 2°C for 16-18 hours in an aerobic atmosphere enriched with 5% carbon dioxide.
Translate the method into controlled worksheet fields: catalogue and lot, preparation mass or volume, water quality, pH where applicable, heating or sterilization, supplements, dispense volume, preparation date, expiry assignment, incubation atmosphere and temperature, reading window, equipment, and analyst. Record departures as deviations instead of silently normalizing them.
Quality control: what the control result protects
1.Control of general characteristics, label and print2.Sterility control7 days at 22 ± 2°C, in aerobiosis7 days at 35 ± 2°C, in aerobiosis3.Microbiological controlInoculum for productivity: 50-100 CFUIncubation Conditions: 16-18 hours at 35 ± 2°C, in aerobic atmosphere with 5% CO2MicroorganismGrowthEscherichia coliATCC 25922GoodHaemophilus influenzaeATCC 49247GoodHaemophilus influenzaeATCC 49766GoodTABLE OF SYMBOLS Batch code In vitro DiagnosticMedical Device Manufacturer Use by Fragile, handle with care Catalogue number Temperature limitation Contains sufficientfor <n> tests Caution, consult
Challenge both sides of performance. Include a target reaction demonstrating recovery and, when relevant, a non-target or alternate reaction challenging inhibition or differentiation. Record expected and observed responses, acceptance criteria, strain and passage, lot, incubation, and disposition. A failed control blocks result interpretation until the cause is resolved.
Interpretation and confirmation pathway
After incubation measure the diameter of the zone of complete inhibition including the diameter of the disc. Interpret zone sizes by referring to the current CLSI procedures and standards. Report the organism as susceptible, intermediate or resistant to the agents thathave been tested.
Record the raw observation before the conclusion: morphology or colour, growth pattern, endpoint, reaction intensity, reading time, and control response. Presumptive reactions remain presumptive. Route atypical, weak, mixed, or delayed reactions through the confirmation step in the current method.
Storage, stability, and pre-use inspection
AND TRANSPORT CONDITIONS2-8°C away from light, until the expiry date on the label. However, our stability studies have shown that the transport at 18-25°C for 4 days, or at 35-39°C for 48 hours, does not alter in any way the
Receipt and storage records should reconstruct temperature exposure, lot rotation, expiry, container integrity, and time outside controlled storage. Inspect colour, clarity, fill volume, gel integrity, contamination, dehydration, and precipitate before use.
Limitations and boundaries of use
The product does not contain hazardous substances in concentrations exceeding the limits set by current legislation and therefore is notclassified as dangerous. It is nevertheless recommended to consult the safety data sheet for its correct use. The product is designed for In vitro diagnostic use and must be used only by properly trained operators.
Applicability depends on matrix, target organism, interfering flora, inoculum, validated method, and regulatory setting. Do not transfer conditions or acceptance criteria from a different matrix without verification.
Troubleshooting from evidence, not guesswork
- Poor recovery: check preparation, pH, overheating, supplement addition, inoculum, atmosphere, storage, and control performance.
- Loss of selectivity: review formulation, sterilization, expiry, inoculum burden, enrichment sequence, and incubation time.
- Weak or atypical reaction: confirm reading time and atmosphere, compare controls, document mixed growth, and follow confirmation requirements.
- Run-to-run drift: trend lot, analyst, equipment, water, preparation batch, controls, and environmental conditions.
External method context
The product should be understood as one measurement component in an antimicrobial susceptibility method. The analytical chain includes isolate purity, standardized inoculum, medium composition, antimicrobial concentration, incubation atmosphere and time, endpoint reading, and the interpretive table selected by the laboratory. A shift in any upstream variable can move an MIC or zone without a change in organism biology, which is why QC distributions and trend review are more informative than a single pass/fail control.
External laboratory-quality guidance also supports a lifecycle view: verify the method when introduced, bridge new lots against an accepted lot, trend control results, investigate nonconformities, and retain enough raw observations to reconstruct the decision. This is the practical difference between reproducing a preparation instruction and demonstrating that the resulting measurement is fit for its intended use.
EUCAST disk diffusion and quality control
EUCAST requires standardized methodology, current breakpoint tables, and routine quality control; the laboratory remains responsible for the final susceptibility report. For broth dilution, inoculum density, cation content, pH, incubation atmosphere, endpoint definition, and two-fold dilution design influence MIC reproducibility. Breakpoints are interpretive rules applied after a technically valid MIC or zone measurement; they are not properties of the product alone. Review the authoritative source.
FDA Bacteriological Analytical Manual
FDA BAM methods organize food microbiology around validated sampling, preparation, enrichment, isolation, and confirmation steps, with method applicability tied to the matrix and target organism. Sampling uncertainty, homogenization efficiency, inhibitory ingredients, dilution design, and countable range can dominate the result before the culture medium is ever inoculated; those variables belong in method verification and uncertainty review. Review the authoritative source.
WHO Laboratory Quality Management System handbook
WHO laboratory quality guidance treats document control, equipment, purchasing and inventory, process control, records, occurrence management, and continual improvement as connected parts of reliable testing. Review the authoritative source.
Technical references
- Manufacturer product documentation for catalogue 10080.
- EUCAST disk diffusion and quality control (access checked 2026-07-20).
- FDA Bacteriological Analytical Manual (access checked 2026-07-20).
- WHO Laboratory Quality Management System handbook (access checked 2026-07-20).
Bench-use checklist
- Verify product identity, catalogue number, lot, expiry, and storage history.
- Document preparation and incubation exactly as controlled in the SOP.
- Define controls and acceptance criteria before testing.
- Record raw observations, control response, reading time, and confirmation decision.
- Escalate failed controls, atypical reactions, and departures through the quality system.